About: http://data.cimple.eu/news-article/8dfdae97fc4188a00562e31df28d04d526dced2ddd8cf568284a7e49

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/8dfdae97fc4188a00562e31df28d04d526dced2ddd8cf568284a7e49 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	EU chief Ursula von der Leyen defended Thursday her handling of the bloc's coronavirus vaccine strategy, but warned that more production and supply problems lie ahead. In an interview with several outlets, including French daily La Croix and Germany's Sueddeutsche Zeitung, von der Leyen admitted Europe could have acted more quickly to boost production capacity. "In Europe, we aim to have 70 percent of the adult population vaccinated before the end of the summer. This is not insignificant, we are moving in the right direction," she said. "There will certainly be other obstacles, other problems in production, and we must also prepare for possible shortages of raw materials or certain components of these vaccines." Von der Leyen also admitted she should never "even have thought" of invoking a clause in the Brexit withdrawal agreement to prevent vaccines crossing the Ireland to Northern Ireland border. This threat, floated in a European Commission export control plan on Friday before being hurriedly abandoned, was denounced in both Dublin and London and embarrassed the Commission. But she defended the broader European vaccine strategy, which has seen the EU Commission negotiate contracts with private pharmaceutical giants on behalf of 27 member state governments. The idea was to avoid competition driving up prices and freezing out smaller EU capitals -- but the US, UK and Israel have raced ahead in terms of vaccinating citizens. "What I realise, looking in the rear view mirror, is that we should have been thinking more about mass production and the challenges it poses," von der Leyen said. "Increasing volumes, setting up new supply chains sufficiently upstream, could have been done earlier," she said. "Now we are working with industry to prepare for the possibility of coronavirus variants that are able to resist vaccines." jug-dc/spm
schema:headline	EU chief warns of more vaccine production delays ahead
schema:mentions	La Croix Clause European Commission House of Leyen Mirror Republic of Ireland Brexit withdrawal agreement Pharmaceutical industry Nazi Germany Ursula von der Leyen Northern Ireland Warini London Israel European Union United Kingdom Vaccine Severe acute respiratory syndrome coronavirus 2 Export Dublin Airport Süddeutsche Zeitung French Third Republic
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	83 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software